Sleep Disorders Trial, Recruiting NCT06767137 Sponsor: Christoph Nissen Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06767137
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with insomnia disorder according to standard diagnostic guidelines (DSM-5)
  • Adults between the ages of 18 and 80 years
  • People who are able to read and sign a consent form agreeing to take part in the study
  • People who speak German or French well enough to understand all information related to the study

Who may not be able to join:

  • People who have an unstable, worsening, or degenerative physical health condition
  • People experiencing acute pain or long-term pain that is not well managed
  • People who are currently having thoughts of suicide
  • People who have a psychiatric condition that is not under control and requires treatment outside of what the study provides
  • People who have a problem with alcohol or drug misuse or dependency
  • People who have been diagnosed with psychosis, bipolar disorder, autism, borderline personality disorder, or antisocial personality disorder
  • People who show signs of a sleep disorder other than insomnia, such as sleep apnea, restless legs syndrome, or sleepwalking (confirm with trial site)
  • People with evidence of an intellectual disability
  • People who regularly take sleeping tablets known as benzodiazepines or related medicines (confirm with trial site for specific medications)
  • People whose medication has changed in the four weeks before the study starts, or who plan to change their medication during the trial
  • People who are currently receiving another form of therapy specifically for insomnia
  • People who are pregnant or breastfeeding
  • People who would not be able to follow the study procedures as required
  • People who do not have sufficient fluency in German or French to complete the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41589440300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Christoph Nissen
Registry
ClinicalTrials.gov
Start date
10 March 2025
Est. completion
1 November 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Insomnia Severity Index (ISI) summary scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov